Business US
Medicare delays GLP-1 coverage plan; interim program extended

Follow us on Google for the latest stock newsFollow Seeking Alpha on Google for the latest stock news
Bill Oxford
The Trump administration has extended a short-term program that offers Medicare coverage for weight loss drugs such as Novo’s (NVO) Wegovy and Lilly’s (LLY) Zepbound after leading health insurers balked at participating in a long-term payment model.
According to the




